Ausgabe 8/2019
Inhalt (15 Artikel)
Novel therapeutic strategy based on genetic and epigenetic abnormalities for myeloid neoplasms
Takahiro Yamauchi
Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
Kenichi Miyamoto, Yosuke Minami
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review
Hiroshi Doi, Kiyoshi Nakamatsu, Yasumasa Nishimura
Immune check-point in endometrial cancer
Francesca De Felice, Claudia Marchetti, Vincenzo Tombolini, P. Benedetti Panici
Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
Kazuo Tamura, Toshihiro Nukiwa, Akihiko Gemma, Nobuyuki Yamamoto, Masaya Mizushima, Kaori Ochai, Rie Ikeda, Hisaya Azuma, Yoichi Nakanishi
FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer
Keiichi Jingu, Rei Umezawa, Takaya Yamamoto, Kazuya Takeda, Yojiro Ishikawa, Noriyoshi Takahashi, Noriyuki Kadoya, Haruo Matsushita
Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study
Jin-Li Wei, Yi-Zhou Jiang, Zhi-Min Shao
Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall
Kyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, Makio Shozu
Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma
Hiroaki Kajiyama, Shiro Suzuki, Fumi Utsumi, Nobuhisa Yoshikawa, Kimihiro Nishino, Yoshiki Ikeda, Kaoru Niimi, Eiko Yamamoto, Michiyasu Kawai, Kiyosumi Shibata, Tetsuro Nagasaka, Fumitaka Kikkawa
Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer
Xiaoxiao Guo, Min Liu, Huimin Hou, Shenjie Liu, Xianbo Zhang, Yaqun Zhang, Pengjie Wu, Cheng Pang, Jianye Wang
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
Kazutaka Sunami, Morio Matsumoto, Shin-ichi Fuchida, Eijiro Omoto, Hiroyuki Takamatsu, Yoko Adachi, Ilsong Choi, Naohito Fujishima, Toru Kiguchi, Toshihiro Miyamoto, Akio Maeda, Junji Suzumiya, Ryosuke Yamamura, Koji Nagafuji, Tomonori Nakazato, Yoshiaki Kuroda, Toshiaki Yujiri, Yasushi Takamatsu, Mine Harada, Koichi Akashi
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma
Congwei Huang, Qinjue Wang, Shengshan Ma, Yang Sun, Ashley Shane Vadamootoo, Chengzhe Jin
Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study
Yuji Okura, Tsugumi Takayama, Kazuyuki Ozaki, Hiroshi Tanaka, Akira Kikuchi, Toshihiro Saito, Toshiki Tanigawa, Yasumasa Takii, Hiroshi Seki, Tatsuya Takenouchi, Takaaki Chou, Nobuaki Sato, Naohito Tanabe, Tohru Minamino
Correction to: Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study
Yuji Okura, Tsugumi Takayama, Kazuyuki Ozaki, Hiroshi Tanaka, Akira Kikuchi, Toshihiro Saito, Toshiki Tanigawa, Yasumasa Takii, Hiroshi Seki, Tatsuya Takenouchi, Takaaki Chou, Nobuaki Sato, Naohito Tanabe, Tohru Minamino